These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 32928093)

  • 1. Therapeutic Applications of Mesenchymal Stem Cells: A Comprehensive Review.
    Samadi P; Saki S; Manoochehri H; Sheykhhasan M
    Curr Stem Cell Res Ther; 2021; 16(3):323-353. PubMed ID: 32928093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on human periapical cyst-mesenchymal stem cells and their potential applications in regenerative medicine.
    Ayoub S; Berbéri A; Fayyad-Kazan M
    Mol Biol Rep; 2020 Mar; 47(3):2381-2389. PubMed ID: 32026284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise Review: Mesenchymal Stem Cells: From Roots to Boost.
    Andrzejewska A; Lukomska B; Janowski M
    Stem Cells; 2019 Jul; 37(7):855-864. PubMed ID: 30977255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?
    El Omar R; Beroud J; Stoltz JF; Menu P; Velot E; Decot V
    Tissue Eng Part B Rev; 2014 Oct; 20(5):523-44. PubMed ID: 24552279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.
    Wu X; Jiang J; Gu Z; Zhang J; Chen Y; Liu X
    Stem Cell Res Ther; 2020 Aug; 11(1):345. PubMed ID: 32771052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.
    Schnabel LV; Abratte CM; Schimenti JC; Felippe MJ; Cassano JM; Southard TL; Cross JA; Fortier LA
    Regen Med; 2014; 9(5):621-35. PubMed ID: 24773530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL; Ruszymah BHI; Ng MH; Law JX
    Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of equine induced pluripotent stem cells into mesenchymal lineage for therapeutic use.
    Chung MJ; Park S; Son JY; Lee JY; Yun HH; Lee EJ; Lee EM; Cho GJ; Lee S; Park HS; Jeong KS
    Cell Cycle; 2019 Nov; 18(21):2954-2971. PubMed ID: 31505996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural compounds and mesenchymal stem cells: implications for inflammatory-impaired tissue regeneration.
    Li W; Xiang Z; Yu W; Huang X; Jiang Q; Abumansour A; Yang Y; Chen C
    Stem Cell Res Ther; 2024 Feb; 15(1):34. PubMed ID: 38321524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells: Cell therapy and regeneration potential.
    Brown C; McKee C; Bakshi S; Walker K; Hakman E; Halassy S; Svinarich D; Dodds R; Govind CK; Chaudhry GR
    J Tissue Eng Regen Med; 2019 Sep; 13(9):1738-1755. PubMed ID: 31216380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muse Cells Provide the Pluripotency of Mesenchymal Stem Cells: Direct Contribution of Muse Cells to Tissue Regeneration.
    Dezawa M
    Cell Transplant; 2016; 25(5):849-61. PubMed ID: 26884346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mesenchymal stem cells - current trends and future prospective.
    Ullah I; Subbarao RB; Rho GJ
    Biosci Rep; 2015 Apr; 35(2):. PubMed ID: 25797907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trafficking and differentiation of mesenchymal stem cells.
    Liu ZJ; Zhuge Y; Velazquez OC
    J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eminent Sources of Adult Mesenchymal Stem Cells and Their Therapeutic Imminence.
    Macrin D; Joseph JP; Pillai AA; Devi A
    Stem Cell Rev Rep; 2017 Dec; 13(6):741-756. PubMed ID: 28812219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systemic Review of Adult Mesenchymal Stem Cell Sources and their Multilineage Differentiation Potential Relevant to Musculoskeletal Tissue Repair and Regeneration.
    Nancarrow-Lei R; Mafi P; Mafi R; Khan W
    Curr Stem Cell Res Ther; 2017; 12(8):601-610. PubMed ID: 28595566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human embryonic stem cell-derived mesenchymal progenitors: an overview.
    Hematti P
    Methods Mol Biol; 2011; 690():163-74. PubMed ID: 21042992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord-derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data.
    Colicchia M; Jones DA; Beirne AM; Hussain M; Weeraman D; Rathod K; Veerapen J; Lowdell M; Mathur A
    Cytotherapy; 2019 Oct; 21(10):1007-1018. PubMed ID: 31540804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin.
    Jakob M; Hambrecht M; Spiegel JL; Kitz J; Canis M; Dressel R; Streckfuss-Bömeke K
    Cells; 2020 Dec; 10(1):. PubMed ID: 33379312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy.
    Fan XL; Zhang Y; Li X; Fu QL
    Cell Mol Life Sci; 2020 Jul; 77(14):2771-2794. PubMed ID: 31965214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.